Liproxstatin-1 analog
- Product Code: 108746
CAS:
1170643-61-4
| Molecular Weight: | 272.39 g./mol | Molecular Formula: | C₁₆H₂₄N₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, sealed |
Product Description:
Liproxstatin-1 analog is primarily utilized in research focused on addressing oxidative stress-related conditions. It serves as a potent inhibitor of ferroptosis, a form of regulated cell death driven by lipid peroxidation. This makes it valuable in studying neurodegenerative diseases, such as Alzheimer's and Parkinson's, where ferroptosis is implicated. Additionally, it is explored in cancer research to understand its potential in protecting healthy cells during chemotherapy, which often induces oxidative damage. The analog is also investigated in ischemia-reperfusion injury models, particularly in cardiac and renal tissues, to mitigate damage caused by the restoration of blood flow after ischemia. Its application extends to preclinical studies aiming to develop therapeutic strategies for diseases linked to oxidative stress and lipid metabolism.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $2,541.57 |
+
-
|
Liproxstatin-1 analog
Liproxstatin-1 analog is primarily utilized in research focused on addressing oxidative stress-related conditions. It serves as a potent inhibitor of ferroptosis, a form of regulated cell death driven by lipid peroxidation. This makes it valuable in studying neurodegenerative diseases, such as Alzheimer's and Parkinson's, where ferroptosis is implicated. Additionally, it is explored in cancer research to understand its potential in protecting healthy cells during chemotherapy, which often induces oxidative damage. The analog is also investigated in ischemia-reperfusion injury models, particularly in cardiac and renal tissues, to mitigate damage caused by the restoration of blood flow after ischemia. Its application extends to preclinical studies aiming to develop therapeutic strategies for diseases linked to oxidative stress and lipid metabolism.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :